Monthly Archives: February 2021

The traditional fee-for-service model of healthcare is an inherently defective one because it leads to a conflict of interest between different stakeholders as it focuses on volume rather than quality of healthcare service. Many countries across the world are now slowly but steadily transitioning from this model to value-based care, where reimbursement to providers is contingent upon measurable clinical outcomes. As patients come centre stage in value-based care and providers become more accountable for the wellness of their patient populations, DTx shows promise by empowering patients. Digital therapeutics can thus be an effective tool for value-based care by leveraging the patient’s healthcare data to augment traditional clinical therapies with actionable intelligence provided to patients and physicians in real time for a more strategic and personalized care.